This article is more than 5 years old. Information may no longer be current.

Calhoun Vision raises $69 million in financing round

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Calhoun Vision announced it raised $69 million in financing, according to a press release.

The financing will support the Light Adjustable Lens, which allows power correction by the physician after cataract surgery. The proceeds will assist with the FDA pre-market process and the company’s marketing strategy, the release said.

Longitude Capital led the financing round with co-investors H.I.G. BioVentures, Balance Point Capital Partners and RA Capital Management. The round raised $52 million in new financing as well as $17 million in debt conversion.

“With this financing, we will strengthen our team, support the company through the FDA submission process, advance our product pipeline and execute our commercial strategy,” Rick Heinick, president and CEO of Calhoun Vision, said in the release.